Clinical Trials on Inhalation Aromatherapy

Total 338 results

Jieqiong Cui

Not yet recruiting

A Clinical Study on the Effects of Inhalation of Volatile Oil of Cang-Ai Via the Nose on Patients With Depression

Depressive Disorder | Mental Disorder in Adolescence
Boehringer Ingelheim

Completed

Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent® Inhalation Aerosol in COPD Patients.

Pulmonary Disease, Chronic Obstructive

United States, Argentina, Lithuania, Slovakia, United Kingdom
Medical University of Warsaw

Completed

Factors Influencing on Correctness of Inhalation Technique.

Asthma | COPD

Poland
Groningen Research Institute for Asthma and COPD

Unknown

Effects of Allergen Inhalation on Adenosine Receptor Expression in Sputum and Peripheral Blood

Healthy | Asthma

Netherlands
VisionHealth GmbH
Thoraxklinik-Heidelberg gGmbH

Recruiting

Effects of the Kata® Inhalations-App on Inhaler Handling Errors, Adherence, and Asthma Control in Patients With Asthma.

Asthma

Germany
Massachusetts General Hospital
National Heart, Lung, and Blood Institute (NHLBI); University of Aarhus

Recruiting

Supplemental Oxygen in Pulmonary Embolism (SO-PE) (SO-PE)

Venous Thromboembolism | Pulmonary Embolism | Metabolomics | Oxygen Inhalation Therapy

United States
Amneal Ireland Limited

Terminated

A BE Study to Compare Beclomethasone Dipropionate Inhalation Aerosol, 40 mcg and QVAR® 40 mcg, Inhalation Aerosol

Asthma

United States
Amphastar Pharmaceuticals, Inc.

Completed

Pharmacokinetics (PK) Study of Epinephrine Inhalation Aerosol in Healthy Volunteers

Asthma

United States
Boehringer Ingelheim

Completed

Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol on Muscular Efficiency and Resting Energy Expenditure (REE) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline

Completed

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol 100/25 Microgram (mcg) Inhalation Powder, Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Fluticasone Propionate 250 mcg Inhalation Powder in Adults and Adolescents With Persistent Asthma

Asthma

United States, Argentina, Germany, Korea, Republic of, Romania, Russian Federation, Spain, Netherlands, Mexico, Brazil, Chile, Czechia
GlaxoSmithKline

Completed

Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once Daily Compared With Tiotropium Bromide Inhalation Powder 18mcg Once Daily in Subjects With COPD Who Have or Are At Risk for Co-morbid Cardiovascular Disease

Pulmonary Disease, Chronic Obstructive

United States, Canada, Germany, Romania, Poland, Czechia
Guangdong Hengrui Pharmaceutical Co., Ltd

Recruiting

Study on Single and Multiple Atomization Inhalation of HRS-9821 Suspension for Inhalation in Healthy Subjects

Chronic Obstructive Pulmonary Disease

China
Respirent Pharmaceuticals Co Ltd.
Becro Ltd.

Recruiting

A Bioequivalence Study Between Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 100 mcg/Blister Oral Inhalation Powder /GSK in Healthy Volunteers Under Fasting Conditions

Asthma | Bioequivalence

Greece
Moscow Clinical Scientific Center
Negovsky Reanimatology Research Institute

Recruiting

The Impact of Inhalation vs Total Intravenous Anesthesia on the Immune Status and Mortality in Patients Undergoing Breast Cancer Surgery: a Prospective Double-Blind Randomized Clinical Trial. (TeMP)

Breast Cancer | Anesthesia

Russian Federation
Respirent Pharmaceuticals Co Ltd.
Becro Ltd.

Active, not recruiting

A Bioequivalence Study Between Fluticasone Propionate 250 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 250 mcg/Blister Oral Inhalation Powder /GSK in Healthy Volunteers Under Fasting Conditions

Asthma | Bioequivalence

Greece
GlaxoSmithKline

Completed

Characterisation of Healthy Volunteers, Asthma and Chronic Obstructive Pulmonary Disease Patients for Inhalation Profile, Pharyngometry, Spirometric Indices and Lung Morphometry

Pulmonary Disease, Chronic Obstructive

Belgium
Boehringer Ingelheim

Completed

Serial Lung Function Measurements in Healthy and Mild Asthmatic Adults After Oral Inhalation of Ethanolic Solutions Containing Two Concentrations of the Excipient Butylated Hydroxytoluene (BHT) Administered With the Respimat® B (RMT-B)

Asthma
Baqiyatallah Medical Sciences University

Completed

Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients

Bronchiolitis

Iran, Islamic Republic of
Elusys Therapeutics

Completed

Intramuscular Dose-Escalation Study With ETI-204 in Adult Volunteers

Inhalational Anthrax

United States
Elusys Therapeutics

Completed

Safety, Tolerability, and PK of a Single Intravenous Dose of ETI-204 in Adult Volunteers

Inhalational Anthrax

United States
Ankara City Hospital Bilkent

Recruiting

Cerebral and Peripheral Near Infrared Spectroscopy Monitoring in Low and High Flow Anaesthesia in Pediatric

Anesthesia | Child, Only | Cerebral Oxygenation | Cerebral Hypoxia | Inhalation; Vapor | Peripheral Oxygenation

Turkey
University Medical Center Groningen
Trudell Medical International

Not yet recruiting

Inhaler Adherence and Inhalation Technique Assessed by a Smart Spacer in Patients With Severe Asthma on Biologics (OUTERSPACE-3)

Asthma

Netherlands
Respirent Pharmaceuticals Co Ltd.
Becro Ltd.

Recruiting

Bioequivalence With Clinical Endpoint Study of Fluticasone Propionate 100 mcg and Salmeterol 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 100/50 mcg Inhalation Powder/GSK in Patients With Asthma (AERO-PD)

Asthma

Greece
Respirent Pharmaceuticals Co Ltd.

Completed

A Clinical Trial for Examining the Therapeutic Equivalence Between Fluticasone Propionate 100 mcg and Salmeterol 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 100/50 mcg Inhalation Powder/GSK in Patients With Asthma

Asthma

Greece
GlaxoSmithKline

Completed

Study Evaluating the Effect of Fluticasone Furoate/ Vilanterol (FF/VI) Inhalation Powder Compared With Vilanterol (VI) Inhalation Powder on Bone Mineral Density (BMD) in Subjects With Chronic Obstructive Pulmonary Disease (COPD).

Pulmonary Disease, Chronic Obstructive

United States, Germany, Spain, Netherlands, Canada
Hamilton Health Sciences Corporation

Completed

The Effect of Allergen Inhalation on Sputum Myeloid and Plasmacytoid Dendritic Cells in Mild Atopic Asthmatics

Asthma

Canada
GlaxoSmithKline

Completed

A Study to Assess the Efficacy of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25 mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50 mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

Germany, Romania, Russian Federation, United States, Ukraine
GlaxoSmithKline

Completed

Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate (FF) /GW642444 (Vilanterol) (VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease

Pulmonary Disease, Chronic Obstructive

Germany, Poland, Romania, United States, Czechia, Russian Federation
Boehringer Ingelheim

Completed

Study of the Comparability of Ipratropium Bromide Hydrofluoroalkane (HFA)-134a Inhalation Aerosol to the Market Standard, Atrovent® Chlorofluorocarbon (CFC) Inhalation Aerosol, in Patients With Chronic Obstructive Pulmonary Disease

Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim

Completed

Multiple Dose Comparison of Tiotropium Inhalation Capsules, Salmeterol Inhalation Aerosol and Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) (COPD)

Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline

Completed

Severe Chronic Obstructive Pulmonary Disease Inhalation Profiles Comparison

Pulmonary Disease, Chronic Obstructive

Belgium
Seoul National University Bundang Hospital

Completed

Intubating Condition After Magnesium Pre-treatment

Heart Rate | Easy of Laryngoscopy Manipulation | Vocal Cord Position or Movement | Patient Reaction to Intubation and Cuff Inflation | Mean Arterial Pressure

Korea, Republic of
Bayer

Completed

Examination of Ventavis (Iloprost) Inhalation Behavior Using the I-Neb AAD System in Patients With Pulmonary Arterial Hypertension When Switching the Iloprost Nebulizer Solution for Inhalation From 10 μg/mL (V10) to 20 μg/mL (V20) (VENTASWITCH)

Hypertension, Pulmonary

Germany
Erzincan Military Hospital

Unknown

Postpartum Oxygen Inhalation for the Treatment of Postpartum Haemorrhage

Postpartum Hemorrhage

Turkey
Boehringer Ingelheim

Completed

A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol.

Pulmonary Disease, Chronic Obstructive

United Kingdom, Turkey, United States, Greece, Portugal, Finland, Italy, Sweden
Medical University of Warsaw

Completed

Comparison of 3 Methods to Assess Inhalation Technique (CINTECH)

Asthma | COPD

Poland
Assistance Publique Hopitaux De Marseille

Terminated

Ex Vivo Pilot Study of the Impact of Nasal Breathing During the Administration of Inhaled Corticosteroids by Inhalation Chamber in Asthmatic Children Ages Between 1 and 4-year-old (MASQUE)

Asthma in Children

France
Elusys Therapeutics

Completed

Safety, Tolerability and PK of Repeat Administration of Intravenous ETI-204 in Adult Volunteers

Inhalational Anthrax

United States
Elusys Therapeutics

Completed

Safety, Tolerability and PK of Intravenous (IV) ETI-204 Alone and in Presence of Ciprofloxacin in Adult Volunteers

Inhalational Anthrax

United States
University of North Carolina, Chapel Hill
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

Identification of Allergic Asthmatics Reactive to Felis Catus (Cat Hair) Allergen Inhalation

Asthma Atopic

United States
Medical University of Bialystok

Completed

Impact of Air Pollution and Climate Changes on the Epidemiology of Cardiovascular Disease (PL-PARTICLES)

Cardiovascular Diseases | Acute Coronary Syndrome | Cardiovascular Risk Factor | Pollution; Exposure | Particulate Matter Inhalation Injury | Chronic Coronary Insufficiency

Poland
Sunovion

Terminated

A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects

Asthma

United States
University Medical Center Groningen

Unknown

Dry Powder Inhalation of Cyclosporine A in Lung Transplant Patients With Bronchiolitis Obliterans Syndrome

Bronchiolitis Obliterans | Lung Transplantation

Netherlands
Emergent BioSolutions
Department of Health and Human Services

Completed

Safety and Pharmacokinetic Study of Anthrax Immune Globulin Derived From Human Serum

Symptoms of Inhalational Anthrax

United States
Fu Jen Catholic University Hospital

Recruiting

The Effect of Perioperative Hydrogen Inhalation on Post-operative Pain and Inflammation Cytokines

Pain, Acute

Taiwan
University of Aarhus

Completed

Analgetic Effect of Nitrousoxide-oxygen Inhalation for Dental Treatment of Children

Dental Pain | Muscle Sensitivity to Pressure | Skin Sensitivity to Electric Stimulation

Denmark
Aerami Therapeutics

Completed

Safety, Tolerability, & Pharmacokinetics Study of Single & Multiple Inhaled Doses of Imatinib Inhalation Solution

Pulmonary Arterial Hypertension

Australia
Insmed Incorporated
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Liposomal Amikacin for Inhalation (LAI) for Nontuberculous Mycobacteria

Mycobacterium Infections, Nontuberculous

United States, Canada
Alkermes, Inc.

Completed

ALK27-001: A Study of Trospium Inhalation Powder (TrIP)Administered to Subjects With COPD

Chronic Obstructive Pulmonary Disease (COPD)

United States
Insmed Incorporated

Terminated

A Study of Treprostinil Palmitil Inhalation Powder (TPIP) In Pulmonary Arterial Hypertension (PAH)

Pulmonary Arterial Hypertension

United States

3

Subscribe